FarFaR - Pharmacy Repository
University of Belgrade, Faculty of Pharmacy
    • English
    • Српски
    • Српски (Serbia)
  • English 
    • English
    • Serbian (Cyrillic)
    • Serbian (Latin)
  • Login
View Item 
  •   FarFaR
  • Pharmacy
  • Doktorati
  • View Item
  •   FarFaR
  • Pharmacy
  • Doktorati
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Uticaj oralne primene Lactobacillus rhamnosus LA68 i Lactobacillus plantarum WCFS1 na imunološke i metaboličke parametre miševa u uslovima eksperimentalno indukovane nealkoholne masne jetre

The effect of oral administration of Lactobacillus rhamnosus LA68 and Lactobacillus plantarum WCFS1 on immunological and metabolic parametres of mice in experimental conditions induced non-alcoholic fatty liver disease

Thumbnail
2016
Disertacija.pdf (2.814Mb)
IzvestajKomisije.pdf (400.2Kb)
Authors
Ivanović, Nevena
Contributors
Minić, Rajna
Stanković, Ivan
Golić, Nataša
Doctoral thesis (Published version)
Metadata
Show full item record
Abstract
Prema definiciji Svetske Zdravstvene Organizacije, probiotici su živi mikroorganizmi kojikada su konzumirani u adekvatnoj količini imaju povoljne efekte na zdravlje domaćina.Pod pojmom probiotskih bakterija misli se većinom na bakterije mlečne kiseline (BMK)koje obuhvataju uglavnom vrste iz rodova Lactobacillus i Bifidobacterium. Rastući je brojdokaza koji ukazuju da primena BMK može ispoljiti povoljne efekte u tretmanukomponenata metaboličkog sindroma, kao što su gojaznost, dijabetes tip 2, dislipidemije,nealkoholna masna bolest jetre (engl. Nonalcoholic Fatty Liver Disease, NAFLD). NAFLDobuhvata čitav spektar oboljenja, počev od hepatične steatoze preko nealkoholnogsteatohepatitisa do hepatične fibroze. Predstavlja najčešći uzrok ozbiljnih i hroničnihoboljenja jetre kod odraslih i kod dece u zapadnim zemljama, sa prevalencom od 20-30% uopštoj odrasloj populaciji, pri čemu prevalenca korelira sa povećanom incidencomgojaznosti i metaboličkog sindroma. Nedavno objavljena istraživanja uk...azuju na ulogucrevne mikrobiote u razvoju steatoze i progresiji NAFLD-a, a s obzirom da probiotici mogudelovati na više nivoa na patogenezu oboljenja, a uz to su još i bezbedni i pristupačni, nijeiznenađujuće što LAB postaju sve privlačniji kao potencijalna dugoročna terapija NAFLDa.Kliničke i eksperimentalne studije sugerišu da se probiotici značajno razlikuju u efektimai mehanizmima dejstva a razlike postoje, ne samo između različitih vrsta, već i izmeđurazličitih soje iste vrste. Zbog toga je najvažniji cilj ove studije bio da se razvije modelNAFLD (stadijum steatoze) ishranom visokog sadržaja masti (VSM), a zatim da se ispita iizvrši poređenje dejstva oralne primene dva različita soja BMK, Lactobacillus rhamnosusLA68 i Lactobacillus plantarum WCFS1, na imunološke i metaboličke parametre, narazvoj steatoze, kao i na sastav masnih kiselina organa kod miševa soja C57BL/6 uuslovima VSM ishrane.Nakon 16 nedelja VSM ishrane, u kojoj je 41% energije poticao od masti, kod miševa sojaC57BL/6 došlo je do značajnog porasta telesne mase, i razvoja steatoze koju je pratioporemećaj lipidnih parametara i porast nivoa leptina, što odgovara početnoj fazi NAFLD(stadijum steatoze)...

According to the World Health Organisation's definition, probiotics are alivemicroorganisms which, when consumed in adequate quantities, have beneficial effects onhost's health. The term probiotics bacteria mostly refers to lactic acid bacteria (LAB)which include species from the genera Lactobacillus and Bifidobacteria. The increasingamount of evidence indicates that the usage of LAB can have positive effects on thetreatment of metabolic syndrome components, such as: obesity, type 2 diabetes,dyslipidemia, nonalcoholic fatty liver disease (NAFLD). NAFLD includes a whole spectarof diseases, starting from hepatic steatosis through nonalcoholic steatohepatitis to hepaticfibrosis which may further progress into ireversibile cirrhosis and hepatocellular carcinoma.NAFLD represents the most common cause of severe and chronic liver diseases in adultsand children in Western countres, with the prevelance correlating with increased incidenceof obesity and metabolic syndrome. Recently published res...earch points to the role ofintestinal microbiota in the development of steatosis and progression of NAFLD.Probiotics, especially LAB, can have an influence on disease pathogenesis at multiplelevels and besides that they are safe and affordable. Taking into account all abovementionedreasons, it is not surprising that LAB are becoming more and more attractive aspotential long-term NAFLD therapy. Clinical and experimental studies suggest that LABdiffer significantly in the effects and mechanisms of action. Those differences are not onlyamong different species but also among different strains within the same species. Becauseof that, the most important goal of this study was to develop a model of NAFLD (steatosisstadium) with use of high fat diet (HFD) and then to examine and to compare the effects oforal administration of two different LAB species/strains, Lactobacillus rhamnosus LA68and Lactobacillus plantarum WCFS1, on immunological and metabolic parameters, onsteatosis development status, as well as on fatty acid composition of liver and brain inC57BL/6 mice under high fat diet regime...

Keywords:
probiotici / probiotics / Lactobacillus / high fat diet / NAFLD / steatosis / laktobacili / ishrana visokog sadržaja masti / NAFLD / steatoza
Source:
Универзитет у Београду, 2016
Publisher:
  • Универзитет у Београду, Фармацеутски факултет
Funding / projects:
  • Allergens, antibodies, enzymes and small physiologically important molecules: design, structure, function and relevance (RS-172049)
  • Develooment and utilization of novel and traditional technologies in production of competitive food products with added valued for national and global market - CREATING WEALTH FROM THE WEALTH OF SERBIA (RS-46001)
[ Google Scholar ]
Handle
https://hdl.handle.net/21.15107/rcub_nardus_6949
URI
http://eteze.bg.ac.rs/application/showtheses?thesesId=4001
https://fedorabg.bg.ac.rs/fedora/get/o:13471/bdef:Content/download
https://fedorabg.bg.ac.rs/fedora/get/o:13587/bdef:Izvestaj/download
http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=48325135
http://nardus.mpn.gov.rs/123456789/6949
https://farfar.pharmacy.bg.ac.rs/handle/123456789/3389
Collections
  • Doktorati
Institution/Community
Pharmacy
TY  - THES
AU  - Ivanović, Nevena
PY  - 2016
UR  - http://eteze.bg.ac.rs/application/showtheses?thesesId=4001
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:13471/bdef:Content/download
UR  - https://fedorabg.bg.ac.rs/fedora/get/o:13587/bdef:Izvestaj/download
UR  - http://vbs.rs/scripts/cobiss?command=DISPLAY&base=70036&RID=48325135
UR  - http://nardus.mpn.gov.rs/123456789/6949
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3389
AB  - Prema definiciji Svetske Zdravstvene Organizacije, probiotici su živi mikroorganizmi kojikada su konzumirani u adekvatnoj količini imaju povoljne efekte na zdravlje domaćina.Pod pojmom probiotskih bakterija misli se većinom na bakterije mlečne kiseline (BMK)koje obuhvataju uglavnom vrste iz rodova Lactobacillus i Bifidobacterium. Rastući je brojdokaza koji ukazuju da primena BMK može ispoljiti povoljne efekte u tretmanukomponenata metaboličkog sindroma, kao što su gojaznost, dijabetes tip 2, dislipidemije,nealkoholna masna bolest jetre (engl. Nonalcoholic Fatty Liver Disease, NAFLD). NAFLDobuhvata čitav spektar oboljenja, počev od hepatične steatoze preko nealkoholnogsteatohepatitisa do hepatične fibroze. Predstavlja najčešći uzrok ozbiljnih i hroničnihoboljenja jetre kod odraslih i kod dece u zapadnim zemljama, sa prevalencom od 20-30% uopštoj odrasloj populaciji, pri čemu prevalenca korelira sa povećanom incidencomgojaznosti i metaboličkog sindroma. Nedavno objavljena istraživanja ukazuju na ulogucrevne mikrobiote u razvoju steatoze i progresiji NAFLD-a, a s obzirom da probiotici mogudelovati na više nivoa na patogenezu oboljenja, a uz to su još i bezbedni i pristupačni, nijeiznenađujuće što LAB postaju sve privlačniji kao potencijalna dugoročna terapija NAFLDa.Kliničke i eksperimentalne studije sugerišu da se probiotici značajno razlikuju u efektimai mehanizmima dejstva a razlike postoje, ne samo između različitih vrsta, već i izmeđurazličitih soje iste vrste. Zbog toga je najvažniji cilj ove studije bio da se razvije modelNAFLD (stadijum steatoze) ishranom visokog sadržaja masti (VSM), a zatim da se ispita iizvrši poređenje dejstva oralne primene dva različita soja BMK, Lactobacillus rhamnosusLA68 i Lactobacillus plantarum WCFS1, na imunološke i metaboličke parametre, narazvoj steatoze, kao i na sastav masnih kiselina organa kod miševa soja C57BL/6 uuslovima VSM ishrane.Nakon 16 nedelja VSM ishrane, u kojoj je 41% energije poticao od masti, kod miševa sojaC57BL/6 došlo je do značajnog porasta telesne mase, i razvoja steatoze koju je pratioporemećaj lipidnih parametara i porast nivoa leptina, što odgovara početnoj fazi NAFLD(stadijum steatoze)...
AB  - According to the World Health Organisation's definition, probiotics are alivemicroorganisms which, when consumed in adequate quantities, have beneficial effects onhost's health. The term probiotics bacteria mostly refers to lactic acid bacteria (LAB)which include species from the genera Lactobacillus and Bifidobacteria. The increasingamount of evidence indicates that the usage of LAB can have positive effects on thetreatment of metabolic syndrome components, such as: obesity, type 2 diabetes,dyslipidemia, nonalcoholic fatty liver disease (NAFLD). NAFLD includes a whole spectarof diseases, starting from hepatic steatosis through nonalcoholic steatohepatitis to hepaticfibrosis which may further progress into ireversibile cirrhosis and hepatocellular carcinoma.NAFLD represents the most common cause of severe and chronic liver diseases in adultsand children in Western countres, with the prevelance correlating with increased incidenceof obesity and metabolic syndrome. Recently published research points to the role ofintestinal microbiota in the development of steatosis and progression of NAFLD.Probiotics, especially LAB, can have an influence on disease pathogenesis at multiplelevels and besides that they are safe and affordable. Taking into account all abovementionedreasons, it is not surprising that LAB are becoming more and more attractive aspotential long-term NAFLD therapy. Clinical and experimental studies suggest that LABdiffer significantly in the effects and mechanisms of action. Those differences are not onlyamong different species but also among different strains within the same species. Becauseof that, the most important goal of this study was to develop a model of NAFLD (steatosisstadium) with use of high fat diet (HFD) and then to examine and to compare the effects oforal administration of two different LAB species/strains, Lactobacillus rhamnosus LA68and Lactobacillus plantarum WCFS1, on immunological and metabolic parameters, onsteatosis development status, as well as on fatty acid composition of liver and brain inC57BL/6 mice under high fat diet regime...
PB  - Универзитет у Београду, Фармацеутски факултет
T2  - Универзитет у Београду
T1  - Uticaj oralne primene Lactobacillus rhamnosus LA68 i Lactobacillus plantarum WCFS1 na imunološke i metaboličke parametre miševa u uslovima eksperimentalno indukovane nealkoholne masne jetre
UR  - https://hdl.handle.net/21.15107/rcub_nardus_6949
ER  - 
@phdthesis{
author = "Ivanović, Nevena",
year = "2016",
abstract = "Prema definiciji Svetske Zdravstvene Organizacije, probiotici su živi mikroorganizmi kojikada su konzumirani u adekvatnoj količini imaju povoljne efekte na zdravlje domaćina.Pod pojmom probiotskih bakterija misli se većinom na bakterije mlečne kiseline (BMK)koje obuhvataju uglavnom vrste iz rodova Lactobacillus i Bifidobacterium. Rastući je brojdokaza koji ukazuju da primena BMK može ispoljiti povoljne efekte u tretmanukomponenata metaboličkog sindroma, kao što su gojaznost, dijabetes tip 2, dislipidemije,nealkoholna masna bolest jetre (engl. Nonalcoholic Fatty Liver Disease, NAFLD). NAFLDobuhvata čitav spektar oboljenja, počev od hepatične steatoze preko nealkoholnogsteatohepatitisa do hepatične fibroze. Predstavlja najčešći uzrok ozbiljnih i hroničnihoboljenja jetre kod odraslih i kod dece u zapadnim zemljama, sa prevalencom od 20-30% uopštoj odrasloj populaciji, pri čemu prevalenca korelira sa povećanom incidencomgojaznosti i metaboličkog sindroma. Nedavno objavljena istraživanja ukazuju na ulogucrevne mikrobiote u razvoju steatoze i progresiji NAFLD-a, a s obzirom da probiotici mogudelovati na više nivoa na patogenezu oboljenja, a uz to su još i bezbedni i pristupačni, nijeiznenađujuće što LAB postaju sve privlačniji kao potencijalna dugoročna terapija NAFLDa.Kliničke i eksperimentalne studije sugerišu da se probiotici značajno razlikuju u efektimai mehanizmima dejstva a razlike postoje, ne samo između različitih vrsta, već i izmeđurazličitih soje iste vrste. Zbog toga je najvažniji cilj ove studije bio da se razvije modelNAFLD (stadijum steatoze) ishranom visokog sadržaja masti (VSM), a zatim da se ispita iizvrši poređenje dejstva oralne primene dva različita soja BMK, Lactobacillus rhamnosusLA68 i Lactobacillus plantarum WCFS1, na imunološke i metaboličke parametre, narazvoj steatoze, kao i na sastav masnih kiselina organa kod miševa soja C57BL/6 uuslovima VSM ishrane.Nakon 16 nedelja VSM ishrane, u kojoj je 41% energije poticao od masti, kod miševa sojaC57BL/6 došlo je do značajnog porasta telesne mase, i razvoja steatoze koju je pratioporemećaj lipidnih parametara i porast nivoa leptina, što odgovara početnoj fazi NAFLD(stadijum steatoze)..., According to the World Health Organisation's definition, probiotics are alivemicroorganisms which, when consumed in adequate quantities, have beneficial effects onhost's health. The term probiotics bacteria mostly refers to lactic acid bacteria (LAB)which include species from the genera Lactobacillus and Bifidobacteria. The increasingamount of evidence indicates that the usage of LAB can have positive effects on thetreatment of metabolic syndrome components, such as: obesity, type 2 diabetes,dyslipidemia, nonalcoholic fatty liver disease (NAFLD). NAFLD includes a whole spectarof diseases, starting from hepatic steatosis through nonalcoholic steatohepatitis to hepaticfibrosis which may further progress into ireversibile cirrhosis and hepatocellular carcinoma.NAFLD represents the most common cause of severe and chronic liver diseases in adultsand children in Western countres, with the prevelance correlating with increased incidenceof obesity and metabolic syndrome. Recently published research points to the role ofintestinal microbiota in the development of steatosis and progression of NAFLD.Probiotics, especially LAB, can have an influence on disease pathogenesis at multiplelevels and besides that they are safe and affordable. Taking into account all abovementionedreasons, it is not surprising that LAB are becoming more and more attractive aspotential long-term NAFLD therapy. Clinical and experimental studies suggest that LABdiffer significantly in the effects and mechanisms of action. Those differences are not onlyamong different species but also among different strains within the same species. Becauseof that, the most important goal of this study was to develop a model of NAFLD (steatosisstadium) with use of high fat diet (HFD) and then to examine and to compare the effects oforal administration of two different LAB species/strains, Lactobacillus rhamnosus LA68and Lactobacillus plantarum WCFS1, on immunological and metabolic parameters, onsteatosis development status, as well as on fatty acid composition of liver and brain inC57BL/6 mice under high fat diet regime...",
publisher = "Универзитет у Београду, Фармацеутски факултет",
journal = "Универзитет у Београду",
title = "Uticaj oralne primene Lactobacillus rhamnosus LA68 i Lactobacillus plantarum WCFS1 na imunološke i metaboličke parametre miševa u uslovima eksperimentalno indukovane nealkoholne masne jetre",
url = "https://hdl.handle.net/21.15107/rcub_nardus_6949"
}
Ivanović, N.. (2016). Uticaj oralne primene Lactobacillus rhamnosus LA68 i Lactobacillus plantarum WCFS1 na imunološke i metaboličke parametre miševa u uslovima eksperimentalno indukovane nealkoholne masne jetre. in Универзитет у Београду
Универзитет у Београду, Фармацеутски факултет..
https://hdl.handle.net/21.15107/rcub_nardus_6949
Ivanović N. Uticaj oralne primene Lactobacillus rhamnosus LA68 i Lactobacillus plantarum WCFS1 na imunološke i metaboličke parametre miševa u uslovima eksperimentalno indukovane nealkoholne masne jetre. in Универзитет у Београду. 2016;.
https://hdl.handle.net/21.15107/rcub_nardus_6949 .
Ivanović, Nevena, "Uticaj oralne primene Lactobacillus rhamnosus LA68 i Lactobacillus plantarum WCFS1 na imunološke i metaboličke parametre miševa u uslovima eksperimentalno indukovane nealkoholne masne jetre" in Универзитет у Београду (2016),
https://hdl.handle.net/21.15107/rcub_nardus_6949 .

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB
 

 

All of DSpaceCommunitiesAuthorsTitlesSubjectsThis institutionAuthorsTitlesSubjects

Statistics

View Usage Statistics

DSpace software copyright © 2002-2015  DuraSpace
About FarFaR - Pharmacy Repository | Send Feedback

OpenAIRERCUB